PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
暂无分享,去创建一个
P. Riedell | U. Jaeger | M. Leung | I. Fleury | L. Pacaud | J. Chu | N. Worel | J. McGuirk | A. Forcina | E. Waller | P. Borchmann